BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22879434)

  • 1. Onco-nephrology: tumor lysis syndrome.
    Wilson FP; Berns JS
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1730-9. PubMed ID: 22879434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor lysis syndrome: new challenges and recent advances.
    Wilson FP; Berns JS
    Adv Chronic Kidney Dis; 2014 Jan; 21(1):18-26. PubMed ID: 24359983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress.
    Matuszkiewicz-Rowinska J; Malyszko J
    Kidney Blood Press Res; 2020; 45(5):645-660. PubMed ID: 32998135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of tumor lysis syndrome.
    Rampello E; Fricia T; Malaguarnera M
    Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of pediatric tumor lysis syndrome.
    Tazi I; Nafl H; Elhoudzi J; Mahmal L; Harif M
    Arab J Nephrol Transplant; 2011 Sep; 4(3):147-54. PubMed ID: 22026339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor lysis syndrome in intensive therapy: diagnostic and therapeutic encare].
    Burghi G; Berrutti D; Manzanares W
    Med Intensiva; 2011 Apr; 35(3):170-8. PubMed ID: 21112673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Lysis Syndrome.
    Barbar T; Jaffer Sathick I
    Adv Chronic Kidney Dis; 2021 Sep; 28(5):438-446.e1. PubMed ID: 35190110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor lysis syndrome: pathogenesis and management.
    Jones DP; Mahmoud H; Chesney RW
    Pediatr Nephrol; 1995 Apr; 9(2):206-12. PubMed ID: 7794722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour lysis syndrome.
    Calvo Villas JM
    Med Clin (Barc); 2019 May; 152(10):397-404. PubMed ID: 30612747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor lysis syndrome: a systematic review of case series and case reports.
    Firwana BM; Hasan R; Hasan N; Alahdab F; Alnahhas I; Hasan S; Varon J
    Postgrad Med; 2012 Mar; 124(2):92-101. PubMed ID: 22437219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarifying the role of rasburicase in tumor lysis syndrome.
    Sood AR; Burry LD; Cheng DK
    Pharmacotherapy; 2007 Jan; 27(1):111-21. PubMed ID: 17192165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pathophysiology, clinical signs and therapy of urate nephropathy].
    Méhes L; Udvardy M; Szász R; Rejto L
    Orv Hetil; 2007 Apr; 148(16):745-8. PubMed ID: 17437951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute renal failure in patients with tumour lysis sindrome].
    Poskurica M; Petrović D; Poskurica M
    Srp Arh Celok Lek; 2016; 144(3-4):232-9. PubMed ID: 27483573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
    Darmon M; Vincent F; Camous L; Canet E; Bonmati C; Braun T; Caillot D; Cornillon J; Dimicoli S; Etienne A; Galicier L; Garnier A; Girault S; Hunault-Berger M; Marolleau JP; Moreau P; Raffoux E; Recher C; Thiebaud A; Thieblemont C; Azoulay E;
    Br J Haematol; 2013 Aug; 162(4):489-97. PubMed ID: 23772757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
    Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor lysis syndrome.
    Jeha S
    Semin Hematol; 2001 Oct; 38(4 Suppl 10):4-8. PubMed ID: 11694945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carfilzomib-induced tumor lysis syndrome in relapsed multiple myeloma: a report of two cases.
    Terzi Demirsoy E; Birtas Atesoglu E; Eren N; Gedük A; Mehtap O; Tarkun P; Hacıhanefioğlu A
    Tumori; 2019 Dec; 105(6):NP24-NP27. PubMed ID: 30580656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor lysis syndrome].
    Mieczkowski M; Matuszkiewicz-Rowińska J; Kościelska M
    Wiad Lek; 2015; 68(4 Pt 2):664-7. PubMed ID: 27162307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The analysis of the risks for the development of tumour lysis syndrome in children.
    Kopecna L; Dolezel Z; Osvaldova Z; Starha J; Hrstkova H
    Bratisl Lek Listy; 2002; 103(6):206-9. PubMed ID: 12448566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
    Mughal TI; Ejaz AA; Foringer JR; Coiffier B
    Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.